Global Pharmaceuticals – Preparing for Challenges Ahead

Click to register for the on-demand.
Click to register for the on-demand.

The sector has solid fundamentals over the next several years but challenges will rise in 2026 and beyond, driving more active M&A and a focus on R&D execution

  • Blockbusters product opportunities
  • Patent cliff exposures
  • Inflation Reduction Act & Proposed European Drug Regulations
  • Biosimilar and generic drug markets
  • Acquisition landscape
  • Speakers keyboard_arrow_down
    image
    Ola Hannoun-Costa Associate Managing Director Moody’s Ratings Bio
    image
    Michael Levesque Senior Vice President Moody's Ratings Bio
    image
    Marie Fischer-Sabatié Senior Vice President Moody's Ratings Bio
    image
    Vladimir Ronin Vice President - Senior Analyst Moody’s Ratings Bio
    image
    Gilberto Ramos Assistant Vice President-Analyst, Corporate Finance Moody’s Ratings Bio
    image
    Martin Hallmark Senior Vice President, Corporate Finance Group Moody's Ratings Bio
    image
    Dean Enjo Vice President – Senior Analyst, Corporate Finance Moody's Investors Service Bio